CD-15 Immunohistochemistry at Lahore PCR Lab

CD-15 Immunohistochemistry at Lahore PCR Lab

CD-15 Immunohistochemistry at Lahore PCR Lab is a highly specialized, state-of-the-art pathological investigation used to identify the expression of the CD15 antigen in tissue specimens. CD15, also known as Lewis X or 3-fucosyl-N-acetyllactosamine, is a carbohydrate adhesion molecule primarily expressed on mature granulocytes, monocytes, and certain epithelial cells. In clinical pathology, the evaluation of CD15 expression is an indispensable diagnostic tool, particularly in the field of hematopathology and oncology. The primary clinical utility of CD-15 Immunohistochemistry (IHC) lies in its ability to confirm the diagnosis of Classical Hodgkin Lymphoma, where it characteristically stains the pathognomonic Reed-Sternberg cells. By utilizing monoclonal antibodies directed against the CD15 antigen, pathologists at Lahore PCR Lab can visualize cellular proteins with exceptional precision, enabling accurate differentiation between benign reactive conditions and malignant neoplasms.

The diagnostic value of CD-15 Immunohistochemistry at Lahore PCR Lab extends beyond hematological malignancies. It plays a critical role in the subtyping of various carcinomas and in distinguishing specific epithelial tumors from mesothelial growths. For instance, CD15 is frequently expressed in adenocarcinomas of the lung, breast, and gastrointestinal tract, while it remains consistently negative in malignant mesotheliomas. This distinction is of paramount clinical importance when oncologists are faced with pleural or peritoneal tumors of uncertain origin. At Lahore PCR Lab, located in Lahore, Pakistan, this advanced diagnostic technique is performed by highly trained histotechnologists and interpreted by experienced consultant pathologists. The laboratory utilizes automated IHC staining platforms to ensure optimal antibody titration, minimal background staining, and highly reproducible results, providing clinicians with the reliable diagnostic insights required to formulate targeted, life-saving treatment plans.

Clinical Procedure: What to Expect

Patient Preparation

Because CD-15 Immunohistochemistry at Lahore PCR Lab is performed on tissue samples that have already been surgically removed or biopsied, there is no direct preparation required from the patient on the day of the laboratory analysis itself. However, patients and referring physicians should observe the following guidelines to ensure a seamless diagnostic workflow:

• Submission of Tissue Blocks and Slides: Patients must submit the formalin-fixed paraffin-embedded (FFPE) tissue block along with the corresponding hematoxylin and eosin (H&E) stained slides and the original histopathology report from the primary biopsy.
• Clinical History Documentation: Provide a comprehensive clinical history, including previous diagnostic reports, imaging findings, and details of any chemotherapy or radiotherapy received, as these can influence tissue morphology and antigen expression.
• Specimen Integrity: Ensure that the tissue block has been processed using standard 10% neutral buffered formalin fixation to preserve antigenicity. Poorly fixed tissue may result in weak or false-negative CD15 staining.
• No Fasting Required: Since the test is performed on an existing tissue specimen, there are no dietary or fluid restrictions for the patient.

During the Procedure

The analytical phase of CD-15 Immunohistochemistry at Lahore PCR Lab involves a series of highly controlled laboratory steps performed on the submitted tissue specimen. Understanding these steps highlights the complexity and precision of the diagnostic process:

• Sectioning: The paraffin block is cut into ultra-thin sections, typically 3 to 4 microns thick, using a precision microtome. These sections are then mounted onto positively charged glass slides to prevent tissue detachment during processing.
• Deparaffinization and Rehydration: The slides are heated and treated with xylene to remove the paraffin wax, followed by graded alcohols to rehydrate the tissue sections back to an aqueous state.
• Antigen Retrieval: To expose the CD15 epitopes that may have been masked during formalin fixation, the slides undergo Heat-Induced Epitope Retrieval (HIER) using a specialized buffer solution under controlled temperature and pressure.
• Antibody Incubation: The tissue sections are incubated with a highly specific primary monoclonal antibody directed against the CD15 antigen. This is followed by the application of a secondary antibody conjugated with a detection polymer system.
• Visualization: A chromogen, typically 3,3'-diaminobenzidine (DAB), is applied, which reacts with the detection system to produce a visible brown precipitate at the site of CD15 antigen localization.
• Counterstaining and Mounting: The slides are counterstained with hematoxylin to visualize cellular nuclei, dehydrated, and sealed with a coverslip for microscopic evaluation.
• Pathologist Evaluation: A consultant pathologist examines the slides under a high-resolution light microscope, assessing the staining intensity, localization (membranous, cytoplasmic, or paranuclear/Golgi-zone), and the percentage of positive cells.

When is a CD-15 Immunohistochemistry Performed?

Suspected Classical Hodgkin Lymphoma

Physicians request CD-15 Immunohistochemistry at Lahore PCR Lab when a patient presents with persistent lymphadenopathy and histological features on an initial biopsy suggest Hodgkin lymphoma. Classical Hodgkin Lymphoma is characterized by the presence of multinucleated Reed-Sternberg cells within an inflammatory background. Because these cells can mimic other atypical lymphoid cells, CD15 staining is performed alongside CD30, CD45, and Pax-5. The characteristic membranous and paranuclear dot-like (Golgi-zone) positivity of CD15 in Reed-Sternberg cells confirms the diagnosis of Classical Hodgkin Lymphoma and rules out Nodular Lymphocyte Predominant Hodgkin Lymphoma, which is typically CD15 negative.

Evaluation of Unexplained Lymphadenopathy

When patients present with unexplained, painless swelling of the lymph nodes, particularly in the cervical, axillary, or inguinal regions, accompanied by systemic symptoms such as night sweats, unexplained fever, and significant weight loss (B-symptoms), a lymph node biopsy is indicated. If the initial microscopic examination reveals an atypical cellular infiltrate, CD-15 Immunohistochemistry at Lahore PCR Lab is performed to determine if the lymphadenopathy is due to a reactive granulocytic proliferation, a classical Hodgkin lymphoma, or a metastatic carcinoma, thereby guiding the clinical team toward the correct therapeutic pathway.

Distinguishing Adenocarcinoma from Mesothelioma

In patients presenting with pleural effusion, ascites, or pleural masses, distinguishing between a primary malignant mesothelioma and a metastatic adenocarcinoma (such as lung or breast cancer) is a common diagnostic challenge. Pathologists routinely utilize a panel of immunohistochemical markers to resolve this dilemma. CD15 is a highly reliable positive marker for adenocarcinoma, showing strong cytoplasmic and membranous staining in the tumor cells, whereas malignant mesotheliomas are almost universally negative for CD15. This differentiation is critical as the treatment protocols and prognoses for these two malignancies differ substantially.

Characterization of Acute Myeloid Leukemia (AML)

CD-15 Immunohistochemistry at Lahore PCR Lab is also utilized in hematopathology to characterize bone marrow trephine biopsies in patients suspected of having Acute Myeloid Leukemia, particularly those with myelomonocytic or monocytic differentiation (such as AML-M4 or AML-M5 under the FAB classification). CD15 is expressed on maturing myeloid cells and can help assess the degree of myeloid differentiation and identify abnormal localization of immature precursors (ALIP) in the bone marrow, which is a key prognostic indicator in myelodysplastic syndromes and leukemic transformations.

Investigating Metastatic Tumors of Unknown Primary

When a patient is found to have a metastatic tumor in an organ like the liver, brain, or bone, but the primary site of the cancer is unknown, immunohistochemical profiling is essential. CD-15 Immunohistochemistry at Lahore PCR Lab is included in diagnostic panels to help identify the epithelial origin of the metastasis. Strong CD15 expression, when combined with other markers like CK7, CK20, TTF-1, or CDX2, helps pathologists narrow down the primary source of the malignancy to the lungs, gastrointestinal tract, or kidneys, enabling oncologists to initiate primary-site-specific systemic therapy.

What Does a CD-15 Immunohistochemistry Detect?

CD-15 Immunohistochemistry at Lahore PCR Lab is designed to detect the presence, distribution, and pattern of the CD15 carbohydrate antigen within tissue sections. Specifically, this diagnostic test detects and evaluates:

• The characteristic membranous staining pattern in classic Reed-Sternberg cells.
• The distinct paranuclear dot-like (Golgi-zone) immunoreactivity in neoplastic cells of Classical Hodgkin Lymphoma.
• Strong cytoplasmic and membranous expression in pulmonary adenocarcinomas.
• The absence of CD15 expression in malignant pleural and peritoneal mesotheliomas.
• CD15-positive mature granulocytes, which serve as an excellent internal positive control within the tissue section.
• The presence of myeloid precursors in bone marrow trephine biopsies.
• Aberrant CD15 expression in certain T-cell lymphomas.
• Expression of CD15 in renal cell carcinomas, particularly of the chromophobe or clear cell subtypes.
• CD15 positivity in papillary thyroid carcinomas.
• The absence of CD15 staining in normal, resting lymphocytes (B and T cells).
• The differentiation between Classical Hodgkin Lymphoma and Nodular Lymphocyte Predominant Hodgkin Lymphoma (which is CD15 negative).
• The presence of CD15 in gastric adenocarcinomas and its correlation with tumor aggressiveness.
• Expression patterns in colorectal carcinomas to assist in prognostic stratification.
• The presence of granulocytic sarcoma (chloroma) in extramedullary sites.
• CD15 expression in normal epithelial structures, such as the renal tubules and gastric mucosa, to confirm tissue preservation.
• The distinction between reactive histiocytic proliferations and myeloid neoplasms.
• The presence of CD15-positive inflammatory infiltrates in chronic inflammatory diseases.
• Co-expression of CD15 and CD30 in neoplastic cells, confirming a classical Hodgkin lymphoma immunophenotype.
• The absence of CD15 in most soft tissue sarcomas, helping in the differential diagnosis of spindle cell tumors.
• The localization of CD15 in salivary gland tumors to assist in subtyping.
• The presence of focal CD15 staining in certain high-grade gliomas.
• The preservation of antigenicity in processed tissue blocks through the staining of internal control cells.

Turnaround Time and Report Access at Lahore PCR Lab

At Lahore PCR Lab, we understand that waiting for pathology results can be an anxious time for patients and their families. The turnaround time for CD-15 Immunohistochemistry at Lahore PCR Lab is typically 3 to 5 working days. This timeframe is necessary to ensure that the tissue blocks are meticulously sectioned, undergo rigorous automated staining protocols, and are thoroughly reviewed by our consultant pathologists, who may also compare the findings with other markers in the immunohistochemical panel to provide a comprehensive and definitive diagnosis.

Once the pathology report is finalized and signed off by the consultant pathologist, it is immediately uploaded to our secure digital database. Patients and referring physicians can access the reports online through the official Lahore PCR Lab web portal. Additionally, for convenience, reports can be sent directly via WhatsApp or email, or collected in person from our main diagnostic center in Lahore. This streamlined reporting process ensures that oncologists and clinicians receive critical diagnostic information without delay, allowing for the timely initiation of appropriate therapeutic interventions.

CD-15 Immunohistochemistry Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Reed-Sternberg Cells (Lymph Node)	Absent (not present in normal lymph nodes)	Strong membranous and paranuclear Golgi-zone CD15 positivity (Classical Hodgkin Lymphoma)
Mature Granulocytes (Internal Control)	Strong, diffuse cytoplasmic and membranous CD15 expression	Decreased or absent staining (indicates poor tissue preservation or technical staining failure)
Mesothelial Cells (Pleura/Peritoneum)	Negative for CD15 expression	Positive CD15 expression (suggests metastatic adenocarcinoma rather than mesothelioma)
Lymphoid Follicles (B and T Cells)	Negative for CD15 expression	Aberrant CD15 expression in rare subtypes of peripheral T-cell lymphomas
Myeloid Precursors (Bone Marrow)	Normal progressive CD15 expression during granulocytic maturation	Increased immature CD15-positive precursors or abnormal localization (ALIP) in AML or MDS
Epithelial Cells (Lung/Colon/Stomach)	Weak to moderate focal CD15 expression in normal luminal membranes	Strong, diffuse cytoplasmic and membranous CD15 expression in adenocarcinomas
L&H Cells (NLPHL Variant)	Absent (not present in normal lymph nodes)	Typically negative for CD15 (helps differentiate NLPHL from Classical Hodgkin Lymphoma)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient's symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for CD-15 Immunohistochemistry?

• Experienced Healthcare Professionals: Our pathology department is led by highly qualified consultant pathologists with specialized training in hematopathology and oncopathology.
• Patient-Focused Care: We prioritize patient comfort and clarity, providing detailed guidance on sample submission and report interpretation.
• Quality Diagnostic Services: Lahore PCR Lab adheres to international standards of quality control, ensuring high diagnostic accuracy for complex immunohistochemical stains.
• Professional Reporting: Our reports are comprehensive, detailed, and structured to provide referring oncologists with all the necessary immunophenotypic data.
• Modern Diagnostic Approach: We utilize advanced automated IHC staining platforms that minimize human error and deliver highly reproducible staining patterns.
• Comfortable Environment: Our sample collection centers in Lahore are designed to provide a clean, professional, and welcoming environment for patients.
• Convenient Location: Strategically located in Lahore, Pakistan, our laboratory is easily accessible for patients submitting tissue blocks from various hospitals.
• Commitment to Accurate Diagnosis: We understand the critical nature of cancer diagnostics and are dedicated to providing precise, timely, and evidence-based results.